2.88
-0.245(-7.85%)
Currency In USD
| Previous Close | 3.12 |
| Open | 2.8 |
| Day High | 3.2 |
| Day Low | 2.74 |
| 52-Week High | 4.92 |
| 52-Week Low | 2.36 |
| Volume | 837,542 |
| Average Volume | 770,082 |
| Market Cap | 215.05M |
| PE | -6.85 |
| EPS | -0.42 |
| Moving Average 50 Days | 3.03 |
| Moving Average 200 Days | 3.44 |
| Change | -0.25 |
If you invested $1000 in OraSure Technologies, Inc. (OSUR) 10 years ago, it would be worth $537.38 as of August 06, 2025 at a share price of $2.875. Whereas If you bought $1000 worth of OraSure Technologies, Inc. (OSUR) shares 5 years ago, it would be worth $219.63 as of August 06, 2025 at a share price of $2.875.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
OraSure Appoints Anne Messing as Chief Commercial Officer
GlobeNewswire Inc.
Aug 04, 2025 11:05 AM GMT
BETHLEHEM, Pa., Aug. 04, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that Anne Messing has joined OTI as Chief Comm
OraSure to Announce Second Quarter 2025 Financial Results and Host Earnings Call on August 5th
GlobeNewswire Inc.
Jul 21, 2025 8:05 PM GMT
BETHLEHEM, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2025 financial results and certain business developments for 5 p.m. ET on August
OraSure Launches Novel Blood Collection Device for Proteomic Research
GlobeNewswire Inc.
Jul 10, 2025 11:05 AM GMT
The device has the potential to transform proteomic discovery through extended protein stabilization and a simplified workflow for researchBETHLEHEM, Pa., July 10, 2025 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader